Answer
Oct 08, 2026 - 10:02 AM
People usually stay on Keytruda (pembrolizumab) for up to two years, depending on how well their cancer responds and whether they experience side effects. The exact duration can vary based on the type of cancer and individual patient circumstances. Your doctor will decide the best length of treatment for you.
